Septic shock caused by Streptococcus pneumoniae in a post-splenectomy patient successfully treated with recombinant human activated protein C

By Schumann Christian   Triantafilou Kathy   Kamenz Joachim   Hanke Hartmut   Triantafilou Martha   Wittemann Silke   Joos Thomas   Hombach Vinzenz   Schneider E. Marion   Lepper Philipp M.  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 2, 2006-02 ,pp. : 139-142

Informa Healthcare

Access to resources Recommend Favorite

Recombinant Factor VII (Activated) for Haemorrhagic Complications of Severe Sepsis Treated with Recombinant Protein C (Activated)

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 126-130

Karger

Access to resources Recommend Favorite

Prognostic Value and Therapeutic Potential of TREM-1 in Streptococcus pyogenes-Induced Sepsis

By  

Journal of Innate Immunity, Vol. 5, Iss. 6, 2013-04 ,pp. : 581-590

Karger

Access to resources Recommend Favorite

Recombinant human activated protein C in sepsis: previous concerns and current usage

By Haley Michael   Cui Xizhong   Minneci Peter C   Deans Katherine J   Natanson Charles   Eichacker Peter Q  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 123-129

Future Medicine

Access to resources Recommend Favorite

Use of recombinant human activated protein C in patients with severe sepsis: a French retrospective multicentre study

By Muller Laurent   Jaber Samir   Raillard Alice   Lefrant Jean  

Intensive Care Medicine, Vol. 34, Iss. 5, 2008-05 ,pp. : 977-979

Springer Publishing Company

Access to resources Recommend Favorite